Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck

William William Jr, Edward Kim, Roy Herbst

Cetuximab increases overall survival in patients with recurrent or metastatic squamous cell carcinomas of the head and neck. Reasonable treatment strategies include the use of first-line platinum, 5-fluorouracil and cetuximab combination, or cetuximab used following progression after a platinum-based regimen.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1